The Dysautonomia Market is rapidly adapting to evolving healthcare landscapes, with an estimated size of USD 2.77 billion in 2024 and a forecast to expand to USD 8.178 billion by 2035. This robust growth, marked by a compound annual growth rate (CAGR) of 10.34%, highlights the urgent need for comprehensive strategies and innovative solutions. As awareness of dysautonomia increases, stakeholders...